NCT05334576 Study of Crizanlizumab for Prevention of Silent Cerebral Infarcts in SCA Status UNKNOWN Phase NA
NCT05329649 Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Severe Sickle Cell Disease (SCD) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05289700 Hyperbaric-oxygen Therapy (HBOT) Versus Placebo for Treating Vaso-Occlusive Crisis (VOC) in Sickle Cell Disease (SCD) Status UNKNOWN Phase PHASE3
NCT05285917 Promoting Utilization and Safety of Hydroxyurea Using Precision in Africa Status RECRUITING Phase PHASE3
NCT05261711 AB1 in Adult Patients with Sickle Cell Disease (SCD) Status TERMINATED Phase PHASE1/PHASE2
NCT05255445 Red Blood Cell - IMProving trAnsfusions for Chronically Transfused Recipients Status COMPLETED Phase N/A
NCT05253781 Low Dose Aspirin for Preventing Intrauterine Growth Restriction and Preeclampsia in Sickle Cell Pregnancy (PIPSICKLE) Status COMPLETED Phase PHASE3
NCT05249452 Adding Azathioprine/Hydroxyurea Preconditioning to Alemtuzumab/TBI to Reduce Risk of Graft Failure in MSD HSCT in Adult SCD Patients Status COMPLETED Phase N/A
NCT05214105 The Predictive Capacity of Machine Learning Models for Progressive Kidney Disease in Individuals With Sickle Cell Anemia Status RECRUITING Phase N/A
NCT05211037 Screening for Renal Complications in Children and Young Adults With Major Sickle Cell Disease Status COMPLETED Phase NA
NCT05203991 Avascular Bone Necrosis in Sickle Cell Disease: a Pediatric Study. Status COMPLETED Phase N/A
NCT05200338 Preservation and Transfer of HBV Immunity After Allogeneic HSCT for SCD Status UNKNOWN Phase NA
NCT05199766 Hemolysis Related Complications in SCD. A Phase II Study With Voxelotor Status UNKNOWN Phase PHASE2